Kang, Minji https://orcid.org/0000-0003-0009-4249
Gulati, Gunsagar S. https://orcid.org/0000-0003-2798-6220
Brown, Erin L. https://orcid.org/0000-0002-0004-3487
Qi, Zhen https://orcid.org/0009-0008-8793-9884
Avagyan, Susanna
Armenteros, Jose Juan Almagro
Gleyzer, Rachel
Zhang, Wubing
Steen, Chloé B.
D’Silva, Jeremy Philip https://orcid.org/0009-0005-0053-7726
Schwab, Janella https://orcid.org/0000-0003-3784-9174
Clarke, Michael F. https://orcid.org/0000-0001-6889-4926
Chaudhuri, Aadel A. https://orcid.org/0000-0003-3115-3061
Newman, Aaron M. https://orcid.org/0000-0002-1857-8172
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA283317, R01CA255450)
Virginia and D.K. Ludwig Fund for Cancer Research
Donald E. and Delia B. Baxter Foundation
SU | Stanford Bio-X
National Science Foundation (DGE-1656518, DGE-1656518, DGE-1656518)
Kirke-, Utdannings- og Forskningsdepartementet (334328)
V Foundation for Cancer Research (V Scholar Award)
Article History
Received: 20 March 2025
Accepted: 2 September 2025
First Online: 27 October 2025
Competing interests
: M.K., G.S.G., E.B., J.J.A.A. and A.M.N. have a patent application (US PCT/US25/18429) related to the identification of developmental states from scRNA-seq data. A.M.N. has ownership interests in CiberMed and LiquidCell Dx. A.A.C. has ownership interests in Droplet Biosciences and LiquidCell Dx. All other authors declare no competing interests.